AbbVie Inc. (ABBV) receives consensus rating of 2.40

The company operates in the Healthcare sector with a market capitalization of 188.41 Million. It offers a line of products for maintenance, repair, remodeling, and decorating. It also provides management services to NewSource Reinsurance Company Ltd.

AbbVie Inc (ABBV) opened at $118.60 on Monday. The Atria Investments Llc holds 77,169 shares with $6.86M value, down from 85,167 last quarter. AbbVie's revenue was up 13.9% on a year-over-year basis. research analysts expect that AbbVie Inc will post 7.46 earnings per share for the current year. The stock increased 1.83% or $2.16 during the last trading session, reaching $120.14.

Among new and sold out positions, 224 holders initiated new positions by a total of 7.41 million shares and 56 holders exited their positions by a total of 9.36 million shares.

AbbVie Inc. (NYSE:ABBV) touched its 1-Year High price of $125.86 on 01/26/18 and its 1-Year Low price of $ 61.30 on 02/22/17. It has underperformed by 6.07% the S&P500. Vanguard Group Inc. now owns 115,920,673 shares of the company's stock valued at $8,405,409,000 after acquiring an additional 3,706,941 shares in the last quarter. Advantus Mngmt Inc owns 161,886 shares for 0.37% of their portfolio. About 3.39 million shares traded. The Australia-based Clenar Muke Llc has invested 7.06% in the stock. Avalon Lc, Texas-based fund reported 152,645 shares. The stock decreased 0.92% or $0.37 during the last trading session, reaching $39.76. About 3.81 million shares traded. Canadian Natural Resources Limited (NYSE:CNQ) has risen 10.32% since February 21, 2017 and is uptrending. It has underperformed by 33.21% the S&P500. 0 analysts gave its stock an Outperform rating. Rating Scale; where 1.0 rating mean Strong Buy, 2.0 rating signifies Buy, 3.0 recommendation reveals Hold, 4.0 rating score shows Sell and 5.0 displays Strong Sell signal. The lowest target is $66.0 while the high is $84.0. The stock has a consensus rating of "Buy" and an average price target of $118.44. The rating was maintained by Jefferies with "Buy" on Friday, January 26. Citigroup maintained the stock with "Neutral" rating in Tuesday, September 13 report. On Thursday, December 8 the stock rating was maintained by RBC Capital Markets with "Outperform". The firm has "Buy" rating by TheStreet given on Tuesday, August 11. The rating was downgraded by JP Morgan on Wednesday, October 26 to "Neutral". The firm has "Buy" rating given on Monday, March 7 by Goldman Sachs. On Friday, June 10 the stock rating was downgraded by BMO Capital Markets to "Market Perform". Hanesbrands Inc. (NYSE:HBI) has declined 23.23% since February 21, 2017 and is downtrending.

A number of research analysts recently issued reports on the company. (NASDAQ:FB). Shoker Counsel Inc holds 0.26% of its portfolio in Facebook, Inc. Gillespie Robinson & Grimm accumulated 2,350 shares. FB's profit will be $4.07 billion for 31.86 P/E if the $1.40 EPS becomes a reality. The institutional investor held 1,600 shares of the hospital and nursing management company at the end of 2017Q3, valued at $95,000, down from 9,500 at the end of the previous reported quarter.

Since August 21, 2017, it had 0 insider purchases, and 32 sales for $470.07 million activity. Brown Cap Mgmt Ltd Liability Corporation holds 0.01% or 6,348 shares in its portfolio. Therefore 48% are positive. Farmers Tru reported 1.13% in AbbVie Inc. The company was maintained on Monday, October 2 by Morgan Stanley. Jefferies maintained the stock with "Buy" rating in Thursday, May 25 report. The firm has "Hold" rating given on Monday, January 29 by Leerink Swann. (NYSE:ABBV). Guinness Atkinson Asset Management reported 3,480 shares. Deutsche Bank upgraded it to "Hold" rating and $88.0 target in Thursday, September 28 report. The rating was maintained by Stifel Nicolaus on Wednesday, October 25 with "Hold". UBS maintained AbbVie Inc. SunTrust Banks lifted their price objective on AbbVie to $157.00 and gave the company an "average" rating in a research report on Monday, January 29th. As per Friday, September 11, the company rating was maintained by Brean Capital.

Mata airs frustration at Mourinho 'lies' following Man Utd reunion
Fabregas unquestionably loves to be on the ball but drastically changed his game in order to help his team. The centre back now reportedly wants reassurances over where his manager sees him in his plans.

The data from the past twelve months tells a different story: insiders executed 21 buys and 37 sells, and ownership decreased by a net of 1.1 million shares. Bedell Frazier Investment Counseling Llc sold 9,562 shares as the company's stock rose 6.17% with the market. On Thursday, December 14 Schumacher Laura J sold $14.07M worth of AbbVie Inc. Old Republic International owns 1.34% invested in McDonald's Corporation (NYSE:MCD) for 258,400 shares.

In related news, SVP Timothy J. Richmond sold 87,040 shares of the company's stock in a transaction on Monday, December 18th. The insider SALEKI-GERHARDT AZITA sold 8,300 shares worth $705,655. Also, VP Robert A. Michael sold 992 shares of the company's stock in a transaction on Tuesday, February 20th.

Comparing the number of shares sold short over time is a method analysts often use to get a reading on investor sentiment. Its down 0.06, from 0.78 in 2017Q2.

Other large investors have also bought and sold shares of the company. 121 funds opened positions while 404 raised stakes. Inr Advisory Limited Com invested in 698 shares.

Decatur Capital Management Inc, which manages about $528.00 million and $521.72 million US Long portfolio, decreased its stake in Adobe Systems Inc. Daiwa Sb Investments Limited reported 0.01% stake. Invsts Asset Of Georgia Incorporated Ga Adv has invested 0.75% in AbbVie Inc. Hudock Capital Group LLC increased its position in shares of AbbVie by 109.5% during the second quarter. 442,340 were accumulated by Boston Private Wealth Ltd Liability Co. Howe Rusling Inc holds 1.97% in AbbVie Inc. It improved, as 52 investors sold AAPL shares while 1034 reduced holdings. Wealthtrust Fairport Ltd Liability Com invested 1.07% of its portfolio in AbbVie Inc. (NYSE:ABBV). Moreover, Lawson Kroeker Invest Inc Ne has 0.13% invested in AbbVie Inc. ABBV's total short interest was 17.47 million shares in February as published by FINRA. Alley Lc reported 42,086 shares.

Latest News